Home/Filings/4/0001181431-05-013886
4//SEC Filing

BIRNDORF HOWARD C 4

Accession 0001181431-05-013886

CIK 0001030339other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 9:30 PM ET

Size

20.3 KB

Accession

0001181431-05-013886

Insider Transaction Report

Form 4
Period: 2005-03-01
BIRNDORF HOWARD C
DirectorExecutive Chairman and CEO
Transactions
  • Sale

    Common Stock

    2005-03-01$4.00/sh10,000$40,000665,552 total
  • Sale

    Common Stock

    2005-03-01$4.03/sh5,000$20,150685,552 total
Holdings
  • Non-Qualified Stock Option

    Exercise: $1.90Exp: 2012-07-26Common Stock (400,000 underlying)
    400,000
  • Non-Qualified Stock Option

    Exercise: $6.00Exp: 2011-07-27Common Stock (70,000 underlying)
    70,000
  • Non-Qualified Stock Option

    Exercise: $5.11Exp: 2012-01-25Common Stock (127,306 underlying)
    127,306
  • Non-Qualified Stock Option

    Exercise: $3.45From: 2004-01-18Exp: 2013-07-18Common Stock (325,000 underlying)
    325,000
  • Non-Qualified Stock Option

    Exercise: $4.70From: 2005-01-29Exp: 2014-07-29Common Stock (282,122 underlying)
    282,122
  • Incentive Stock Option

    Exercise: $4.70From: 2005-01-29Exp: 2014-07-29Common Stock (17,878 underlying)
    17,878
  • Incentive Stock Option

    Exercise: $5.11Exp: 2012-01-25Common Stock (22,694 underlying)
    22,694
  • Non-Qualified Stock Option

    Exercise: $11.94Exp: 2011-01-26Common Stock (80,000 underlying)
    80,000
  • Incentive Stock Option

    Exercise: $4.50Exp: 2009-01-22Common Stock (25,000 underlying)
    25,000
Footnotes (2)
  • [F1]The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 selling plan adopted by Howard Birndorf on February 23, 2004.
  • [F2]Various exercise dates for previously reported holding.

Issuer

NANOGEN INC

CIK 0001030339

Entity typeother

Related Parties

1
  • filerCIK 0001078432

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 9:30 PM ET
Size
20.3 KB